Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Prof Oriel Thekisoe receives prestigious TW Kambule NRF-NSTF Award
2014-07-07

 Prof Oriel Thekisoe
Photo: Sonia Small
Prof Oriel Thekisoe from the UFS was named recipient of the prestigious TW Kambule NRF-NSTF Award. The announcement was made during the 16th Annual NSTF-BHP Billiton 2013/2014 Awards Gala Dinner held in Johannesburg on Thursday 3 July 2014.

Prof Thekisoe is an Associate Professor in the university's Department of Zoology and Entomology at the Qwaqwa Campus.

He has been recognised as an emerging researcher for his outstanding contribution to Science, Engineering and Technology (SET).

"It is a great honour for the university to learn that Prof Thekisoe has won the award of the National Science and Technology Forum. This is a very competitive award and speaks of the quality and depth of talent at the UFS as we prepare the next generation of scientists and scholars,” said Vice-Chancellor and Rector of the UFS, Prof Jonathan Jansen.

"I hope that the award will inspire our current science students to work harder in pursuing the discovery of new methods and techniques which will improve our livelihoods,” Prof Thekisoe said after receiving the award from the Minister of Science and Technology, Ms Naledi Pandor. “I am grateful to the Dean of the Faculty of Natural and Agricultural Sciences, Prof Neil Heideman, for believing in me. I am also grateful to my former lecturers, Profs Peter Mbati, who is now the Rector of the University of Venda, and Noboru Inoue, from Japan’s Obihiro University, for grooming and inspiring the scientist in me.”

"Prof Thekisoe is at the forefront of the research development activities at the Qwaqwa Campus,” said Prof Corli Witthuhn, Vice-Rector: Research at the UFS. “He serves as a mentor to many of the younger scholars on the campus. As one of the Vice-Chancellor's Prestige Scholars at the university, he has the potential to become one of the most prominent researchers in his field in the country."

The Vice-Chancellor’s Prestige Programme (PSP) supports the accelerated scholarship of junior UFS researchers in the first five years after obtaining their PhDs. The prestige scholars participate in an intensive programme of support that includes international placement and intensive mentorship.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept